Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-24

Clinical Trial Update: Real-Life Evaluation of Guselkumab Dosing Interval Adjustments

View source ↗

Summary

A real-life study evaluating adjustments to guselkumab dosing intervals for psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Guselkumab (guselkumab)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Psoriasis | Status: RECRUITING